Prostate cancer is a second leading cause of cancer of cancer just in men. It’s a serious problem with surgery as the only treatment option to completely remove the gland along with the cancer. But now patients have a choice: traditional open surgery or robotic prostate removal. It’s a medical advancement that doctors and patients consider to be the future of prostate cancer treatment
Over 200,000 American men are diagnosed with prostate cancer each year. The New England Journal of Medicine has just released a new study showing the long-term benefits of two different common methods of prostate cancer treatment, watchful waiting and surgical prostate removal (most commonly done now through a procedure called a robotic prostatectomy).
Dr. David Samadi, leading robotic prostatectomy surgeon, joins Dr. Marc Siegel to discuss new research supporting the benefits of undergoing robotic prostate cancer surgery at teaching hospitals. Data reviewed indicates fewer complications, less blood loss and better outcomes than non-academic hospitals.
Views: 361 Channel name: News Max
Watchful Waiting the Wait and See Approach to Prostate Cancer
Dr. David Samadi appears on News Max Health to discuss the wait and see approach and what it means for those suffering from prostate cancer.
DAVID B. SAMADI, M.D. Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, and Professor of Urology at Hofstra North Shore-LIJ School of Medicine 485 Madison Avenue, 21st floor, New York, NY 10022 Tel: 1-212-365-5000 | Fax: 1-646-692-6744